Telethon Kids Institute to lead COVID-19 drug trial

06/05/2020 - 13:44

Telethon Kids Institute has received $2.66 million from BHP to lead a trial testing the effectiveness of multiple sclerosis drug interferon in reducing the infectiousness of COVID-19 patients.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options